3xERRE/ERE-luciferase Citations (5)

Originally described in: ERK/MAPK regulates ERRgamma expression, transcriptional activity, and receptor-mediated Tamoxifen resistance in ER+ breast cancer.
Heckler MM, Thakor H, Schafer CC, Riggins RB FEBS J. 2014 Mar 29. doi: 10.1111/febs.12797. PubMed Journal

---

Articles Citing 3xERRE/ERE-luciferase

Articles
Novel Promising Estrogenic Receptor Modulators: Cytotoxic and Estrogenic Activity of Benzanilides and Dithiobenzanilides. Kucinska M, Giron MD, Piotrowska H, Lisiak N, Granig WH, Lopez-Jaramillo FJ, Salto R, Murias M, Erker T. PLoS One. 2016 Jan 5;11(1):e0145615. doi: 10.1371/journal.pone.0145615. eCollection 2016. PubMed
Determination and analysis of agonist and antagonist potential of naturally occurring flavonoids for estrogen receptor (ERalpha) by various parameters and molecular modelling approach. Puranik NV, Srivastava P, Bhatt G, John Mary DJS, Limaye AM, Sivaraman J. Sci Rep. 2019 May 15;9(1):7450. doi: 10.1038/s41598-019-43768-5. PubMed
A conserved mechanism of sirtuin signalling through steroid hormone receptors. Bayele HK. Biosci Rep. 2019 Dec 20;39(12). pii: 221190. doi: 10.1042/BSR20193535. PubMed
Optical Control of Small Molecule-Induced Protein Degradation. Naro Y, Darrah K, Deiters A. J Am Chem Soc. 2020 Feb 5;142(5):2193-2197. doi: 10.1021/jacs.9b12718. Epub 2020 Jan 23. PubMed
Discovery of novel antagonists targeting the DNA binding domain of androgen receptor by integrated docking-based virtual screening and bioassays. Pang JP, Shen C, Zhou WF, Wang YX, Shan LH, Chai X, Shao Y, Hu XP, Zhu F, Zhu DY, Xiao L, Xu L, Xu XH, Li D, Hou TJ. Acta Pharmacol Sin. 2021 Mar 25. pii: 10.1038/s41401-021-00632-5. doi: 10.1038/s41401-021-00632-5. PubMed

If you have published an article using this material, please email us at to have your article added to this page.